{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:27:15Z","timestamp":1785472035277,"version":"3.56.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.2169\/internalmedicine.2572-23","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T22:12:40Z","timestamp":1699222360000},"page":"1771-1776","source":"Crossref","is-referenced-by-count":3,"title":["Minimal Change Nephrotic Syndrome Secondary to Methotrexate-associated Hodgkin Lymphoma"],"prefix":"10.2169","volume":"63","author":[{"given":"Misa","family":"Iimori","sequence":"first","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sonomura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Matsushita Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ueyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Oobayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Matsushita Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuka","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Japanese Red Cross Kyoto Daiichi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol 12: 332-345, 2017.","DOI":"10.2215\/CJN.05000516"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 69: 2251-2260, 2006.","DOI":"10.1038\/sj.ki.5000341"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56: 355-377, 1999.","DOI":"10.1046\/j.1523-1755.1999.00548.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int 30: 465-473, 1986.","DOI":"10.1038\/ki.1986.209"},{"key":"5","unstructured":"5. Gaulard P. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: WHO Classification Tumours Haematopoietic Lymphoid Tissues. International Agency for Research on Cancer, Lyon, 2008: 350-351."},{"key":"6","unstructured":"6. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741-1743, 1991."},{"key":"7","unstructured":"7. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Miyazaki T, Fujimaki K, Shirasugi Y, et al. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol 82: 1106-1109, 2007.","DOI":"10.1002\/ajh.21003"},{"key":"9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"9. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556-560, 1974.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsai JD, Lee HC, Lin CC, et al. Epstein-Barr virus-associated acute renal failure: diagnosis, treatment, and follow-up. Pediatr Nephrol 18: 667-674, 2003.","DOI":"10.1007\/s00467-003-1152-y"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Okada H, Ikeda N, Kobayashi T, et al. An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron 92: 440-444, 2002.","DOI":"10.1159\/000063322"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Joshi A, Arora A, Cimbaluk D, Dunea G, Hart P. Acute Epstein-Barr virus infection-associated collapsing glomerulopathy. Clin Kidney J 5: 320-322, 2012.","DOI":"10.1093\/ckj\/sfs059"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2572-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:29:31Z","timestamp":1718422171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2572-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2572-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"article-number":"2572-23"}}